BETH FAIMAN: Open Payments
NPI 1629032313 · CLEVELAND, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$40,002 in 53 payments from 8 companies in 2025. Trend: 2023 $24,675 · 2024 $25,236 · 2025 $40,002
Consulting: $26,035Grant: $10,683Speaker / faculty: $1,750Food & beverage: $917Travel & lodging: $617
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $16,754 |
| GENZYME CORPORATION | 14 | $13,517 |
| Janssen Global Services, LLC | 4 | $3,750 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $3,100 |
| The Binding Site Inc. | 1 | $1,750 |
| PFIZER INC. | 3 | $675 |
| Legend Biotech USA Inc. | 11 | $315 |
| E.R. Squibb & Sons, L.L.C. | 1 | $141 |
Products named: DARZALEX, SARCLISA, TALVEY, Freelite, ELREXFIO, CARVYKTI, RYBREVANT.
Industry payments across OH — which companies pay providers there.
